Gliflozins in the Management of Cardiovascular Disease

被引：142
作者：
Braunwald, Eugene [1 ,2 ,3 ]
机构：
[1] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Hale Bldg Transformat Med,Suite 7022,60 Fenwood Rd, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Boston, MA USA
[3] Harvard Med Sch, Dept Med, Boston, MA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 386卷 / 21期
关键词：
COTRANSPORTER; 2; INHIBITORS; REDUCED EJECTION FRACTION; SGLT2; HEART-FAILURE; DIABETES-MELLITUS; KIDNEY-DISEASE; EMPAGLIFLOZIN; DEATH; NA+; DAPAGLIFLOZIN;
D O I：
10.1056/NEJMra2115011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gliflozins in Cardiac and Renal DiseaseGliflozins - sodium-glucose cotransporter 2 inhibitors - lower blood glucose and glycated hemoglobin in patients with type 2 diabetes without causing hypoglycemia. The agents also improve cardiac function in patients who have heart failure with or without type 2 diabetes and improve renal function, with few adverse effects.
引用
收藏
页码：2024 / 2034
页数：11
相关论文
共 87 条
  • [1] T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats
    Adachi, T
    Yasuda, K
    Okamoto, Y
    Shihara, N
    Oku, A
    Ueta, K
    Kitamura, K
    Saito, A
    Iwakura, T
    Yamada, Y
    Yano, H
    Seino, Y
    Tsuda, K
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (08): : 990 - 995
  • [2] 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S144 - S174
  • [3] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1451 - 1461
  • [4] [Anonymous], 2022, Food and Drug Administration
  • [5] Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
    Batzias, Konstantinos
    Antonopoulos, Alexios S.
    Oikonomou, Evangelos
    Siasos, Gerasimos
    Bletsa, Evanthia
    Stampouloglou, Panagiota K.
    Mistakidi, Chara-Vasiliki
    Noutsou, Marina
    Katsiki, Niki
    Karopoulos, Periklis
    Charalambous, Georgios
    Thanopoulou, Anastasia
    Tentolouris, Nicholas
    Tousoulis, Dimitris
    [J]. JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [6] Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
    Bhatt, Deepak L.
    Szarek, Michael
    Steg, P. Gabriel
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Voors, Adriaan A.
    Metra, Marco
    Lund, Lars H.
    Komajda, Michel
    Testani, Jeffrey M.
    Wilcox, Christopher S.
    Ponikowski, Piotr
    Lopes, Renato D.
    Verma, Subodh
    Lapuerta, Pablo
    Pitt, Bertram
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) : 117 - 128
  • [7] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
    Bhatt, Deepak L.
    Szarek, Michael
    Pitt, Bertram
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Cherney, David Z. I.
    Dwyer, Jamie P.
    Scirica, Benjamin M.
    Bailey, Clifford J.
    Diaz, Rafael
    Ray, Kausik K.
    Udell, Jacob A.
    Lopes, Renato D.
    Lapuerta, Pablo
    Steg, P. Gabriel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) : 129 - 139
  • [8] Diabetes, heart failure, and renal dysfunction: The vicious circles
    Braunwald, Eugene
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2019, 62 (04) : 298 - 302
  • [9] SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
    Brown, Emily
    Heerspink, Hiddo J. L.
    Cuthbertson, Daniel J.
    Wilding, John P. H.
    [J]. LANCET, 2021, 398 (10296) : 262 - 276
  • [10] Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
    Butler, Javed
    Packer, Milton
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Zeller, Cordula
    Schnee, Janet
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Anker, Stefan D.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (05) : 416 - 426
123456789